How SOX2 Causes Immune Suppression in Oral Cancer
Author Information
Author(s): Taner Hülya F., Gong Wang, Fitzsimonds Zackary R., Li Zaiye, Wu Yuesong, He Yumin, Okuyama Kohei, Cheng Wanqing, Kuczura Jung, Rajesh Sashider, Manousidaki Andriana, Feng Shuo, Lee Miki, Nör Felipe, Lanzel Emily, Demehri Shadmehr, Polverini Peter J., Nör Jacques E., Wang Thomas D., Que Jianwen, Wen Haitao, Xie Yuying, Moon James J., Lei Yu Leo
Primary Institution: University of Texas MD Anderson Cancer Center
Hypothesis
Does SOX2 expression in precancerous lesions lead to immune suppression and malignant transformation?
Conclusion
The study identifies a SOX2-CCL2-IL1 pathway that drives immune suppression and increases the risk of malignant transformation in precancerous lesions.
Supporting Evidence
- SOX2 expression in precancerous lesions recruits immune suppressive myeloid cells.
- IL-1α priming desensitizes myeloid cells to immune activation.
- Blockade of IL-1 signaling reduces the risk of malignant transformation.
- High levels of SLC2A1 in tumors correlate with reduced T-cell infiltration.
- SOX2-driven transformation alters the immune landscape before cancer develops.
Takeaway
When a certain protein called SOX2 is present in early mouth lesions, it can trick the immune system into not fighting the bad cells, making it easier for those cells to turn into cancer.
Methodology
The study used a genetically engineered mouse model and longitudinal human specimens to analyze immune cell profiles and signaling pathways.
Potential Biases
Potential bias in the interpretation of immune cell interactions due to the model used.
Limitations
The study primarily focuses on a specific signaling pathway and may not account for other factors influencing immune suppression.
Participant Demographics
The study involved human specimens from patients with SOX2+ oral epithelial dysplasia and head and neck squamous cell carcinoma.
Statistical Information
P-Value
0.00021
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website